1. Home
  2. NE vs BBIO Comparison

NE vs BBIO Comparison

Compare NE & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NE
  • BBIO
  • Stock Information
  • Founded
  • NE 1985
  • BBIO 2015
  • Country
  • NE United States
  • BBIO United States
  • Employees
  • NE N/A
  • BBIO N/A
  • Industry
  • NE Other Specialty Stores
  • BBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • NE Consumer Discretionary
  • BBIO Health Care
  • Exchange
  • NE Nasdaq
  • BBIO Nasdaq
  • Market Cap
  • NE 6.1B
  • BBIO 5.1B
  • IPO Year
  • NE N/A
  • BBIO 2019
  • Fundamental
  • Price
  • NE $30.57
  • BBIO $27.30
  • Analyst Decision
  • NE Buy
  • BBIO Strong Buy
  • Analyst Count
  • NE 7
  • BBIO 13
  • Target Price
  • NE $48.00
  • BBIO $47.92
  • AVG Volume (30 Days)
  • NE 1.7M
  • BBIO 2.5M
  • Earning Date
  • NE 11-05-2024
  • BBIO 11-12-2024
  • Dividend Yield
  • NE 5.95%
  • BBIO N/A
  • EPS Growth
  • NE 5.74
  • BBIO N/A
  • EPS
  • NE 3.40
  • BBIO N/A
  • Revenue
  • NE $2,645,919,000.00
  • BBIO $217,765,000.00
  • Revenue This Year
  • NE $26.94
  • BBIO $2,648.47
  • Revenue Next Year
  • NE $16.51
  • BBIO N/A
  • P/E Ratio
  • NE $8.98
  • BBIO N/A
  • Revenue Growth
  • NE 8.51
  • BBIO 2209.77
  • 52 Week Low
  • NE $29.72
  • BBIO $21.62
  • 52 Week High
  • NE $52.16
  • BBIO $44.32
  • Technical
  • Relative Strength Index (RSI)
  • NE 36.56
  • BBIO 57.33
  • Support Level
  • NE $29.70
  • BBIO $27.17
  • Resistance Level
  • NE $32.92
  • BBIO $29.99
  • Average True Range (ATR)
  • NE 0.88
  • BBIO 1.15
  • MACD
  • NE -0.27
  • BBIO -0.00
  • Stochastic Oscillator
  • NE 23.58
  • BBIO 47.66

About NE Noble Corporation plc A

Noble Corp PLC is an offshore drilling contractor for the oil and gas industry that provides contract drilling services to the international oil and gas industry with its fleet of mobile offshore drilling units. The company focuses on a high-specification fleet of floating and jackup rigs and the deployment of its drilling rigs in oil and gas basins around the world.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: